Dev

Although past research has associated obesity with increased risk of dementia, a new study – deemed the largest ever to assess the link between body mass index and dementia risk – suggests obesity could actually be a protective factor against…

New research highlights how nerves – whether harmed by disease or traumatic injury – start to die, a discovery that unveils novel targets for developing drugs to slow or halt peripheral neuropathies and devastating neurodegenerative disorders such as Alzheimer’s disease,…

The Joint Programming initiative (JPI) “More Years, Better Lives“ aims at coordinating national and European research activities in the field of demographic change. The first call of Joint Programming Initiative (JPI) “More Years, Better Lives” was officially launched on 1…

In their latest brain imaging study on women at risk for Alzheimer’s disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a…

Translational research for neurodegenerative disease depends intimately upon animal models. Unfortunately, promising therapies developed using mouse models mostly fail in clinical trials, highlighting uncertainty about how well mouse models mimic human neurodegenerative disease at the molecular level. This study compared…

The Joint Programming Initiative “A Healthy Diet for A Healthy Life” has launched a joint transnational call for research proposals in the area of Nutrition and Cognitive Function. The joint action “Nutrition and Cognitive Function” (NutriCog) aims at promoting research…

Five months into his five-year term as research commissioner, Carlos Moedas spoke to Nature Magazine about his hopes and ambitions for the scientific programmes run by the European Union (EU), particularly the huge seven-year €80-billion (US$86-billion) Horizon 2020 (H2020) research…

The Dementia Discovery Fund, which is being established by the UK government with initial commitments totalling $100 million, brings together leading pharmaceutical companies, the UK government and Alzheimer’s Research UK to address the rising threat posed by dementia by supporting…